Recently, relevant studies have shown that the occurrence of type II diabetes and its common complications is closely related to the inflammatory response, and tumor necrosis factor-α and interleukin factors are clinically common inflammatory response markers that can effectively predict the incidence of type II diabetes [14–16]. This evidence concerns the gene TNF and type 2 diabetes mellitus.